Deutsche Bank Maintains 'Top Pick' on DaVita (DVA); Raising PT on Pending HealthCare Partners Acquisition

Article Stock Quotes (1) Comments (0)

Deutsche Bank maintains a 'Buy' on DaVita (NYSE: DVA) price target of $114.00 (from $104.00).

Deutsche analyst said, "We are increasing our valuation target on DVA by $10 per share based on our view that the earnings from the pending HealthCare Partners (HCP) acquisition will sustain a higher multiple than we originally thought."

"DVA continues to be a top sector pick. We remain constructive on the solid L-T growth characteristics of the base dialysis business, and we are bullish on the potential of the HCP business vertical."

For an analyst ratings summary and ratings history on DaVita click here. For more ratings news on DaVita click here.

Shares of DaVita closed at $98.21 yesterday, with a 52 week range of $59.14-$98.21.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
• Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
• Urban Outfitters (URBN) Added to Best Ideas List at Janney Capital on Solid Q1 Results

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Deutsche Bank, Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?